Trial · NCT02149264
Results by group110
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 110
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percentage of Subjects Whose Average Concentration (Cave(0-24)) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL | Testosterone Gel (FE 999303) | 76.1 | 95% Confidence Interval 69.4 to 82.8 | percentage of subjects | |
| The Percentage of Subjects Whose Cave(0-24) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL | Testosterone Gel (FE 999303) | Day 14 | 29.1 | percentage of subjects | |
| The Percentage of Subjects Whose Cave(0-24) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL | Testosterone Gel (FE 999303) | Day 35 | 58.2 | percentage of subjects | |
| The Percentage of Subjects Whose Cave(0-24) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL | Testosterone Gel (FE 999303) | Day 56 | 71.2 | percentage of subjects | |
| Change From Baseline in International Index of Erectile Function (IIEF) Score | Testosterone Gel (FE 999303) | Day 35 | 8.4 | Standard Deviation 13.2 | units on a scale |
| Change From Baseline in International Index of Erectile Function (IIEF) Score | Testosterone Gel (FE 999303) | Day 90 | 14.4 | Standard Deviation 16.9 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Severity domain score at Day 35 | -3.6 | Standard Deviation 4.8 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Distress domain score at Day 35 | -1.7 | Standard Deviation 2.6 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Degree of interference domain score at Day 35 | -13.6 | Standard Deviation 24.1 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Timing domain score at Day 35 | -2.6 | Standard Deviation 3.3 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | GFI score at Day 35 | -8.3 | Standard Deviation 10.1 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Severity domain score at Day 90 | -5.2 | Standard Deviation 4.9 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Distress domain score at Day 90 | -2.2 | Standard Deviation 2.5 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Degree of interference domain score at Day 90 | -16.7 | Standard Deviation 24.5 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | Timing domain score at Day 90 | -3.0 | Standard Deviation 3.4 | units on a scale |
| Change From Baseline in Multidimensional Assessment of Fatigue (MAF) Score | Testosterone Gel (FE 999303) | GFI score at Day 90 | -12.0 | Standard Deviation 11.1 | units on a scale |
| Change From Baseline in Short Form-12 Health Survey (SF-12) Score | Testosterone Gel (FE 999303) | PCS Day 35 | 1.2 | Standard Deviation 7.0 | units on a scale |
| Change From Baseline in Short Form-12 Health Survey (SF-12) Score | Testosterone Gel (FE 999303) | PCS Day 90 | 1.8 | Standard Deviation 7.1 | units on a scale |
| Change From Baseline in Short Form-12 Health Survey (SF-12) Score | Testosterone Gel (FE 999303) | MCS Day 35 | 6.3 | Standard Deviation 9.5 | units on a scale |
| Change From Baseline in Short Form-12 Health Survey (SF-12) Score | Testosterone Gel (FE 999303) | MCS Day 90 | 6.5 | Standard Deviation 10.1 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02149264/results